{
    "organizations": [],
    "uuid": "3b21e9c628cd309d56dd18b8dd830ee1b1d72c18",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vical-announces-restructuring-to-f/brief-vical-announces-restructuring-to-focus-resources-on-hsv-2-and-antifungal-clinical-programs-idUSASB0C331",
    "ord_in_thread": 0,
    "title": "BRIEF-Vical Announces Restructuring To Focus Resources On Hsv-2 And Antifungal Clinical Programs",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Vical Inc:\n* VICAL ANNOUNCES RESTRUCTURING TO FOCUS RESOURCES ON HSV-2 AND ANTIFUNGAL CLINICAL PROGRAMS\n* VICAL INC - ‍RESTRUCTURING INCLUDES A REDUCTION IN STAFF OF APPROXIMATELY 54%, FROM 74 TO 34 EMPLOYEES​\n* VICAL INC - ‍COMPANY IS TERMINATING ALL ACTIVITIES RELATED TO ASP0113 PROGRAM LICENSED TO ASTELLAS PHARMA​\n* VICAL INC - ‍BELIEVES ITS CURRENTLY AVAILABLE CASH AND INVESTMENTS WILL BE ADEQUATE TO FUND OPERATIONS AT LEAST THROUGH 2019​\n* VICAL INC - ‍RESTRUCTURING TO CONSERVE CAPITAL AND TO FOCUS EFFORTS ON VL-2397 AND ON COMPLETING PHASE 2 HSV-2 CLINICAL TRIAL​\n* VICAL INC - ‍EXPECTS TO REPORT THAT IT ENDED 2017 WITH CASH AND INVESTMENTS OF APPROXIMATELY $60 TO $65 MILLION​\n* VICAL INC - ‍CASH BURN FOR 2017 IS EXPECTED TO BE AT LOW END OF VICAL‘S GUIDANCE OF $8 TO $11 MILLION​\n* VICAL INC - ‍EXPECTS TO INCUR PERSONNEL-RELATED RESTRUCTURING CHARGES OF APPROXIMATELY $1.1 MILLION IN Q1 OF 2018​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-31T05:45:00.000+02:00",
    "crawled": "2018-01-31T16:36:48.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "vical",
        "inc",
        "vical",
        "announces",
        "restructuring",
        "focus",
        "resource",
        "antifungal",
        "clinical",
        "program",
        "vical",
        "inc",
        "includes",
        "reduction",
        "staff",
        "approximately",
        "vical",
        "inc",
        "terminating",
        "activity",
        "related",
        "asp0113",
        "program",
        "licensed",
        "astellas",
        "vical",
        "inc",
        "currently",
        "available",
        "cash",
        "investment",
        "adequate",
        "fund",
        "operation",
        "least",
        "vical",
        "inc",
        "conserve",
        "capital",
        "focus",
        "effort",
        "completing",
        "phase",
        "clinical",
        "vical",
        "inc",
        "report",
        "ended",
        "cash",
        "investment",
        "approximately",
        "vical",
        "inc",
        "burn",
        "expected",
        "low",
        "end",
        "vical",
        "guidance",
        "vical",
        "inc",
        "incur",
        "restructuring",
        "charge",
        "approximately",
        "million",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}